Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Cardiac Safety Study of an Investigational Drug to See How if Affects the Heart in People With Parkinson's Disease Complicated by Motor Fluctuations "OFF" Episodes

ClinicalTrials.gov ID: NCT03187301

Public ClinicalTrials.gov record NCT03187301. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 6:58 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-Blind, Placebo Controlled, 3-Period Crossover, Positive Control, QT-Evaluation Study of APL-130277 in Subjects With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A cardiac safety study of an investigational drug to see how it affects the heart in people with Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

Study identification

NCT ID
NCT03187301
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
48 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 3, 2017 (Actual)
Primary completion
Dec 21, 2017 (Actual)
Completion
Dec 21, 2017 (Actual)
Last update posted
Aug 10, 2020

2017

United States locations

U.S. sites
10
U.S. states
8
U.S. cities
10
Facility City State ZIP Site status
Movement Disorders Center of Arizona Scottsdale Arizona 85258 —
Clinical Trials, Inc. Little Rock Arkansas 72205 —
The Parkinson's and Movement Disorder Institute Fountain Valley California 92708 —
Parkinson's Disease and Movement Disorders Center of Boca Raton Boca Raton Florida 33486 —
MD Clinical Hallandale Florida 33009 —
Bioclinica Reserach Orlando Florida 32806 —
Atlanta Center for Medical Research Atlanta Georgia 30331 —
The NeuroMedical Center, PC Baton Rouge Louisiana 70810 —
QUEST Research Institute Farmington Hills Michigan 48334 —
Central Texas Neurology Consultants Round Rock Texas 78681 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03187301, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 10, 2020 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03187301 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →